Heyuan Biotech announced that it plans to repurchase the company's shares through centralized bidding transactions. The total repurchase capital is not less than RMB 25 million, not more than RMB 50 million, and the repurchase price is not higher than RMB 9 per share. The purpose of repurchasing shares is to protect the company's value and shareholders' rights. The repurchased shares will be sold using centralized bidding 12 months after disclosure of the repurchase implementation results and share change announcements, and the sale will be completed within 3 years after disclosure of the repurchase results and share change announcements; if the sale is not completed within the above period, the registered capital reduction procedure will be carried out in accordance with law, and the purchased shares that have not yet been sold will be cancelled. The repurchase period is within 3 months from the date the board of directors reviewed and approved the repurchase plan.

Heyuan Biotech announced that it plans to repurchase the company's shares through centralized bidding transactions. The total repurchase capital is not less than RMB 25 million, not more than RMB 50 million, and the repurchase price is not higher than RMB 9 per share. The purpose of repurchasing shares is to protect the company's value and shareholders' rights. The repurchased shares will be sold using centralized bidding 12 months after disclosure of the repurchase implementation results and share change announcements, and the sale will be completed within 3 years after disclosure of the repurchase results and share change announcements; if the sale is not completed within the above period, the registered capital reduction procedure will be carried out in accordance with law, and the purchased shares that have not yet been sold will be cancelled. The repurchase period is within 3 months from the date the board of directors reviewed and approved the repurchase plan.